[Review of problems in the treatment of the parkinsonian syndrome with L-dopa].
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D007980:Levodopa / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D009069:Movement Disorders / Q000139:chemically induced; D010302:Parkinson Disease, Secondary / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced
D007980:Levodopa
Aggiornamento sui problemi della terapia della sindrome parkinsoniana con L-dopa